Evidence map›Paper›PMID 40537580›Full record

ReviewFunctional & integrative genomics2025

Multi-omics approaches: transforming the landscape of natural product isolation.

Soumitra Sahana, Jyotirmay Sarkar, Sourav Mandal, Indranil Chatterjee, Susmita Dhar, Samaresh Datta, Sumanta Mondal

Abstract readReview
PubMed Publisher
In one paragraph

Review in Functional & integrative genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Special Issue "Natural Products as Multitarget Agents in Human Diseases".International journal of molecular sciences · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Mechanism, Efficacy, and Safety of Natural Antibiotics.Antibiotics (Basel, Switzerland) · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Soumitra SahanaDepartment of Pharmacognosy, Birbhum Pharmacy School, Kolkata, West Bengal, India. sahana2001dipu@gmail.com.ORCID http://orcid.org/0000-0003-4372-5899
Jyotirmay SarkarFaculty of Pharmacy, C. V. Raman Global University, Bhubaneswar, Odisha, India.
Sourav MandalDepartment of Pharmaceutical Technology, JIS University, Kolkata, West Bengal, India.
Indranil ChatterjeeDepartment of Pharmaceutical Technology, JIS University, Kolkata, West Bengal, India.
Susmita DharDepartment of Pharmaceutical Chemistry, Birbhum Pharmacy School, Kolkata, West Bengal, India.
Samaresh DattaDepartment of Pharmaceutical Chemistry, Birbhum Pharmacy School, Kolkata, West Bengal, India.
Sumanta MondalDepartment of Pharmaceutical Chemistry, School of Pharmacy, GITAM (Deemed to Be University), Visakhapatnam A.P., India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The field of natural product (NPs) discovery has significantly evolved with the advent of multi-omics approaches, encompassing genomics, transcriptomics, proteomics, and metabolomics. This review highlighting targeted isolation strategies and the comprehensive applications of omics in investigating natural products. Omics technologies, including genomics, transcriptomics, proteomics, and metabolomics, have emerged as powerful tools that revolutionize the traditional methods of natural product discovery. This review delves into the integration of multi-omics technology in the isolation and discovery of natural product. Omics applications in natural product investigation have revolutionized the field by enabling high-throughput screening, rapid identification of novel compounds, and understanding the complex interactions within biological systems. For instance, metabolomics gives insights into the metabolic profiles of organisms under different conditions, aiding in the discovery of unique NPs with potential therapeutic applications. Genomics has facilitated the mining of microbial genomes for biosynthetic gene clusters, leading to the discovery of new antibiotics and carcinopreventive agents. Transcriptomics and proteomics provide insights into gene expression and protein synthesis, revealing the dynamics of NPs biosynthesis under various conditions. Despite these limitations, the future prospects of multi-omics in natural product discovery are promising. Advances in omics technologies, coupled with machine learning and artificial intelligence, are expected to enhance data integration and predictive modeling, accelerating the discovery and development of innovative drugs. Furthermore, the continuous improvement in analytical techniques and the establishment of comprehensive databases will facilitate the identification and characterization of NPs, ultimately contributing to the development of new therapeutic agents. Collaborative efforts across disciplines and the integration of environmental and ecological data will further enhance our understanding of NP biosynthesis and lead to more effective and sustainable drug discovery strategies.

Indexed as

Biological ProductsGenomicsMetabolomicsProteomicsDrug DiscoveryHumansMultiomicsTranscriptomeBiological ProductsDrug discoveryGenomicsIsolationMetabolomicsMulti-omicsNatural productsProteomicsTranscriptomics

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.